Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.
about
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblastsInduction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulationsIntralymphatic immunotherapyNewcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigsAIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.Allergen immunotherapy: routes, safety, efficacy, and mode of action.Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodesMucosal challenge with cell-associated or cell-free feline immunodeficiency virus induces rapid and distinctly different patterns of phenotypic change in the mucosal and systemic immune systems.Major histocompatibility complex class I (FLA-E*01801) molecular structure in domestic cats demonstrates species-specific characteristics in presenting viral antigen peptides.
P2860
Q34342119-3EB38276-430E-4146-9D12-7E45767060CDQ34641666-51E96446-DD27-4EFD-B3ED-B723A60ADA4BQ35155423-0DD3CB0B-6DF6-4805-B41F-1241BD4C3370Q35275117-40204577-D2C9-4648-BAA0-4C3DD77DC52BQ36473694-FEEC9AD3-F117-40BF-929C-0E98083CD9BBQ36970017-A030C045-A96B-4A56-9ACB-236CF5392C1DQ38912244-842DB1A0-A6C5-4FE7-8CEE-68F1FF05BE3FQ39756926-CD356B16-88D5-4831-9572-8F4538E13A73Q44870958-431A59EE-831D-4BCC-BD6D-9BBE2EF0CD9AQ47562618-DE25CD0A-73CA-4A87-8FA0-71F51B8EE38B
P2860
Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Targeted lymph node immunizati ...... feline immunodeficiency virus.
@en
Targeted lymph node immunizati ...... feline immunodeficiency virus.
@nl
type
label
Targeted lymph node immunizati ...... feline immunodeficiency virus.
@en
Targeted lymph node immunizati ...... feline immunodeficiency virus.
@nl
prefLabel
Targeted lymph node immunizati ...... feline immunodeficiency virus.
@en
Targeted lymph node immunizati ...... feline immunodeficiency virus.
@nl
P2093
P1433
P1476
Targeted lymph node immunizati ...... feline immunodeficiency virus
@en
P2093
C R Stokes
D A Harbour
T J Gruffydd-Jones
T J Hillman
P356
10.1016/S0264-410X(01)00323-1
P407
P577
2001-10-01T00:00:00Z